NCT06576882View on ClinicalTrials.gov

7 Days vs. 14 Days of Vonoprazan-based Triple Therapy for H. Pylori Eradication

PHASE3CompletedINTERVENTIONAL
Enrollment

326

Participants

Timeline

Start Date

June 30, 2024

Primary Completion Date

November 1, 2024

Study Completion Date

December 1, 2024

Conditions
Helicobacter Pylori InfectionGastritisVonoprazanAdolescents
Interventions
DRUG

Vonoprazan

Participants will receive Vonoprazan 20 mg tablets twice daily before meals.

DRUG

Amoxicillin

Participants will receive Amoxicillin 50 mg/kg/day capsules or suspension \[maximum daily dose: 2 g\].

DRUG

Clarithromycin

Participants will receive Clarithromycin 20 mg/kg/day tablets or suspension \[maximum daily dose: 1 g\].

Trial Locations (1)

Unknown

Faculty of Medicine, Alexandria University., Alexandria

All Listed Sponsors
lead

Alexandria University

OTHER

NCT06576882 - 7 Days vs. 14 Days of Vonoprazan-based Triple Therapy for H. Pylori Eradication | Biotech Hunter | Biotech Hunter